Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

9.78
+0.57006.19%
Post-market: 9.780.00000.00%19:30 EDT
Volume:1.76M
Turnover:17.03M
Market Cap:1.65B
PE:-5.76
High:9.86
Open:9.31
Low:9.31
Close:9.21
52wk High:11.66
52wk Low:4.35
Shares:168.65M
Float Shares:130.00M
Volume Ratio:1.24
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.68
PE(LYR):-3.09

Loading ...

Vir Biotechnology Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Feb 25

BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet

Reuters
·
Feb 24

Vir Biotechnology Up Nearly 34%, on Pace for Largest Percent Increase Since January 2025 -- Data Talk

Dow Jones
·
Feb 24

Vir Biotechnology price target raised to $18 from $14 at Needham

TIPRANKS
·
Feb 24

BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy

Reuters
·
Feb 24

This Small-Cap Biotech Stock Is Soaring 35% on Excitement Over Its Prostate Cancer Drug -- Barrons.com

Dow Jones
·
Feb 24

These Stocks Are Today's Movers: AMD, Home Depot, Novo Nordisk, Hims & Hers, Keysight, Vir Biotechnology, and More -- Barrons.com

Dow Jones
·
Feb 24

Top Premarket Gainers

MT Newswires Live
·
Feb 24

BUZZ-U.S. STOCKS ON THE MOVE-Home Depot, Keysight Technologies, Vir Biotechnology

Reuters
·
Feb 24

Vir Biotechnology Is Maintained at Buy by Needham

Dow Jones
·
Feb 24

U.S. Stocks to Watch: Hims & Hers, IBM, BWX, Kratos, Diamondback, Vir, Home Depot, and More

Dow Jones
·
Feb 24

Vir Biotechnology Inc : Morgan Stanley Raises Target Price to $24.00 From $20.00

THOMSON REUTERS
·
Feb 24

BUZZ-Vir Biotechnology soars on Q4 results beat, Astellas collaboration

Reuters
·
Feb 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Summit Therapeutics (SMMT)

TIPRANKS
·
Feb 24

Premarket Movers | Vir Biotech Soars 53%; Keysight Technologies Gains 15%; SanDisk Jumps over 2%; Novo Nordisk Falls 3%

Tiger Newspress
·
Feb 24

Stock Track | Vir Biotechnology Soars 51.68% in Pre-Market on Major Astellas Collaboration, Positive Clinical Data and Strong Earnings

Stock Track
·
Feb 24

Vir Biotechnology Shares Jump 49% Premarket After Q4 Revenue Beat, Co to Develop Prostate Cancer Drug With Japan's Astellas

THOMSON REUTERS
·
Feb 24

Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Vir Biotechnology (VIR)

TIPRANKS
·
Feb 24

Vir Biotech Catapults 58% on A $1.71 Billion Deal With Astellas

Tiger Newspress
·
Feb 24

Stock Track | Vir Biotechnology Soars 56.12% on Major Astellas Collaboration, Positive Clinical Data and Strong Earnings

Stock Track
·
Feb 24